Galecto Inc
NASDAQ:GLTO
Galecto Inc
NASDAQ:GLTO
Price:
0.705 USD
-0.72%
Market Closed
Updated:
May 9, 2024
Galecto Inc
EPS (Diluted)
|
Galecto Inc
EPS (Diluted) Peer Comparison
Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Galecto Inc
NASDAQ:GLTO
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
EPS (Diluted)
kr83
|
CAGR 3-Years
-1%
|
CAGR 5-Years
31%
|
CAGR 10-Years
42%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
EPS (Diluted)
-kr12
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
EPS (Diluted)
-€8
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
EPS (Diluted)
kr19
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bioporto A/S
CSE:BIOPOR
|
EPS (Diluted)
kr0
|
CAGR 3-Years
18%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-2%
|
See Also
What is Galecto Inc's EPS (Diluted)?
EPS (Diluted)
-1.4
USD
-1.4
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's EPS (Diluted) amounts to -1.4 USD.
What is Galecto Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-13%
-13%
Over the last year, the EPS (Diluted) growth was 41%. The average annual EPS (Diluted) growth rates for Galecto Inc have been -1% over the past three years , -13% over the past five years .
You don't have any saved screeners yet
